China · Delayed Price · Currency is CNY Xiamen Amoytop Biotech Statistics
Total Valuation
SHA:688278 has a market cap or net worth of CNY 23.04 billion. The enterprise value is 22.14 billion.
| Market Cap | 23.04B |
| Enterprise Value | 22.14B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
SHA:688278 has 408.19 million shares outstanding. The number of shares has increased by 0.64% in one year.
| Current Share Class | 408.19M |
| Shares Outstanding | 408.19M |
| Shares Change (YoY) | +0.64% |
| Shares Change (QoQ) | -1.70% |
| Owned by Insiders (%) | 50.13% |
| Owned by Institutions (%) | 17.79% |
| Float | 161.56M |
Valuation Ratios
The trailing PE ratio is 22.88 and the forward PE ratio is 18.05.
| PE Ratio | 22.88 |
| Forward PE | 18.05 |
| PS Ratio | 6.03 |
| PB Ratio | 6.35 |
| P/TBV Ratio | 7.15 |
| P/FCF Ratio | 59.73 |
| P/OCF Ratio | 35.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.68, with an EV/FCF ratio of 57.40.
| EV / Earnings | 21.84 |
| EV / Sales | 5.80 |
| EV / EBITDA | 16.68 |
| EV / EBIT | 18.55 |
| EV / FCF | 57.40 |
Financial Position
The company has a current ratio of 4.79, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.79 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.48 |
| Interest Coverage | 837.92 |
Financial Efficiency
Return on equity (ROE) is 31.78% and return on invested capital (ROIC) is 39.56%.
| Return on Equity (ROE) | 31.78% |
| Return on Assets (ROA) | 19.52% |
| Return on Invested Capital (ROIC) | 39.56% |
| Return on Capital Employed (ROCE) | 30.75% |
| Weighted Average Cost of Capital (WACC) | 3.53% |
| Revenue Per Employee | 1.05M |
| Profits Per Employee | 278,156 |
| Employee Count | 3,644 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, SHA:688278 has paid 131.60 million in taxes.
| Income Tax | 131.60M |
| Effective Tax Rate | 11.49% |
Stock Price Statistics
The stock price has decreased by -25.34% in the last 52 weeks. The beta is -0.13, so SHA:688278's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -25.34% |
| 50-Day Moving Average | 67.02 |
| 200-Day Moving Average | 76.39 |
| Relative Strength Index (RSI) | 29.59 |
| Average Volume (20 Days) | 2,915,139 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688278 had revenue of CNY 3.82 billion and earned 1.01 billion in profits. Earnings per share was 2.47.
| Revenue | 3.82B |
| Gross Profit | 3.52B |
| Operating Income | 1.19B |
| Pretax Income | 1.15B |
| Net Income | 1.01B |
| EBITDA | 1.32B |
| EBIT | 1.19B |
| Earnings Per Share (EPS) | 2.47 |
Balance Sheet
The company has 1.09 billion in cash and 186.88 million in debt, with a net cash position of 899.77 million or 2.20 per share.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 186.88M |
| Net Cash | 899.77M |
| Net Cash Per Share | 2.20 |
| Equity (Book Value) | 3.63B |
| Book Value Per Share | 8.83 |
| Working Capital | 2.20B |
Cash Flow
In the last 12 months, operating cash flow was 657.02 million and capital expenditures -271.30 million, giving a free cash flow of 385.72 million.
| Operating Cash Flow | 657.02M |
| Capital Expenditures | -271.30M |
| Depreciation & Amortization | 124.98M |
| Net Borrowing | 135.16M |
| Free Cash Flow | 385.72M |
| FCF Per Share | 0.94 |
Margins
Gross margin is 92.19%, with operating and profit margins of 31.25% and 26.53%.
| Gross Margin | 92.19% |
| Operating Margin | 31.25% |
| Pretax Margin | 29.98% |
| Profit Margin | 26.53% |
| EBITDA Margin | 34.52% |
| EBIT Margin | 31.25% |
| FCF Margin | 10.10% |
Dividends & Yields
This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 1.06%.
| Dividend Per Share | 0.62 |
| Dividend Yield | 1.06% |
| Dividend Growth (YoY) | 51.22% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 24.99% |
| Buyback Yield | -0.64% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 4.40% |
| FCF Yield | 1.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |